Filing Details
- Accession Number:
- 0001213900-25-013481
- Form Type:
- 13G Filing
- Publication Date:
- 2025-02-12 19:00:00
- Filed By:
- Sudhir Srivastava, M.D.
- Company:
- Ss Innovations International Inc.
- Filing Date:
- 2025-02-13
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
|---|---|---|---|
| Sudhir Srivastava, M.D. | 0 | 107,818,790 | 63.1% |
| Sushruta PVT LTD | 0 | 103,421,589 | 60.5% |
| Sudhir Srivastava Innovations PTE LTD | 0 | 0 | 0% |
Filing
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)
|
SS Innovations International, Inc. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
05453U203 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 05453U203 |
| 1 | Names of Reporting Persons
Sudhir Srivastava, M.D. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
107,818,790.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
63.1 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: Consists of (a) 103,197,140 shares of Common Stock of the Company held by Sushruta PVT LTD; (b) 7% Convertible One-Year Promissory Note held by Sushruta PVT LTD convertible into 224,719 shares of Common Stock of the Company; (c) 32,000 shares of Common Stock of the Company held by Dr. Srivastava; and (d) Options held by Dr. Srivastava to purchase 4,364,931 shares of Common Stock of the Company. Dr. Srivastava has a 100% interest in Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD. Percentage in Row 11 is calculated based on 170,873,415 shares of common stock outstanding as of January 14, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.
SCHEDULE 13G
|
| CUSIP No. | 05453U203 |
| 1 | Names of Reporting Persons
Sushruta PVT LTD | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
BAHAMAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
103,421,589.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
60.5 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
OO |
Comment for Type of Reporting Person: Row 5 and Row 7 consists of (a) 103,197,140 shares of Common Stock of the Company held by Sushruta PVT LTD; and (b) 7% Convertible One-Year Promissory Note held by Sushruta PVT LTD convertible into 224,719 shares of Common Stock of the Company. Percentage in Row 11 is calculated based on 170,873,415 shares of common stock outstanding as of January 14, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.
SCHEDULE 13G
|
| CUSIP No. | 05453U203 |
| 1 | Names of Reporting Persons
Sudhir Srivastava Innovations PTE LTD | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
SINGAPORE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
OO |
Comment for Type of Reporting Person: Percentage in Row 11 is calculated based on 170,873,415 shares of common stock outstanding as of January 14, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
SS Innovations International, Inc. | |
| (b) | Address of issuer's principal executive offices:
1600 SE 15th Street, #512 Fort Lauderdale, FL 33316 | |
| Item 2. | ||
| (a) | Name of person filing:
(1) Sudhir Srivastava, M.D.
(2) Sushruta PVT LTD
(3) Sudhir Srivastava Innovations PTE LTD | |
| (b) | Address or principal business office or, if none, residence:
The address for Sudhir Srivastava, M.D., Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD is as follows:
1600 SE 15th Street, #512
Fort Lauderdale, FL 33316 | |
| (c) | Citizenship:
Sudhir Srivastava, M.D. - USA
Sushruta PVT LTD - Commonwealth of the Bahamas
Sudhir Srivastava Innovations PTE LTD - Singapore | |
| (d) | Title of class of securities:
Common Stock | |
| (e) | CUSIP No.:
05453U203 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
(1) Sudhir Srivastava, M.D. - 107,818,790
(2) Sushruta PVT LTD - 103,421,859
(3) Sudhir Srivastava Innovations PTE LTD - 0 | |
| (b) | Percent of class:
(1) Sudhir Srivastava, M.D. - 63.1%
(2) Sushruta PVT LTD - 60.5%
(3) Sudhir Srivastava Innovations PTE LTD - .0%
All calculations of percentage ownership herein are based upon an aggregate of 170,873,415 shares of common stock outstanding as of January 14, 2025, as reported by the Issuer in its September 30, 2023 Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on January 14, 2025. | |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
(1) Sudhir Srivastava, M.D. - 107,818,790
(2) Sushruta PVT LTD - 103,421,859
(3) Sudhir Srivastava Innovations PTE LTD - 0 | ||
| (ii) Shared power to vote or to direct the vote:
(1) Sudhir Srivastava, M.D. - 0
(2) Sushruta PVT LTD - 0
(3) Sudhir Prem Srivastava - 0 | ||
| (iii) Sole power to dispose or to direct the disposition of:
(1) Sudhir Srivastava, M.D. - 107,818,790
(2) Sushruta PVT LTD - 103,421,859
(3) Sudhir Srivastava Innovations PTE LTD - 0 | ||
| (iv) Shared power to dispose or to direct the disposition of:
(1) Sudhir Srivastava, M.D. - 0
(2) Sushruta PVT LTD - 0
(3) Sudhir Prem Srivastava Innovations PTE LTD - 0 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
The shares of common stock referenced in Item 4, Section (a) above include shares held of record by Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD. Dr. Srivastava owns a 100% beneficial interest in Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD. | ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
Exhibit Information
|
JOINT FILING AGREEMENT |